Research has documented numerous conflicts of interest (COI) in which pharmaceutical industry money is paid to researchers, APA board members, New studies reveal that conflicted FDA speakers are up to ...
Biotheranostics, Inc., today announced new data demonstrating how the Breast Cancer Index® (BCI™) Test results influence ...
Agendia will present two posters highlighting how its tests provide insights into treatment response and aid therapeutic ...
Patients in Iowa will soon no longer need to wonder if their health insurance companies will approve certain care their ...
Sky Labs (CEO Jack ByungHwan Lee) announced on the 26th that its ring-type cuffless blood pressure monitor, 'CART BP pro,' ...
USA: A cohort study highlighted a significant gap between evidence and real-world practice in patients with newly identified heart failure with reduced ejection fraction (HFrEF). Nearly two-thirds of ...
May 2026Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor ...
Providers of AI systems in the EU should find it easier to understand whether those systems constitute ‘high-risk’ AI systems ...
Most health care professionals in the U.S. said they would consider prescribing combination levothyroxine and liothyronine ...
Mark Jermin, TikTok-famous talent agent to 'Harry Potter' & 'Wednesday' actors, admits mishandling self-tape auditions and ...
2don MSN
Why surveillance pricing bans are suddenly gaining traction this year (and not just in California)
This year, with voters across the country facing rising inflation and an affordability crisis, lawmakers in various states are cracking down.
Immigration lawyers say the change could impact a wide swath of people and marks an escalation in the administration’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results